Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
by
Guo, Li
, Zhang, Dingyu
, Qu, Zhaohui
, Peng, Lu
, Li, Kunxia
, Jaki, Thomas
, Ruan, Shunan
, Hayden, Frederick G
, Chen, Nanshan
, He, Jing
, Shang, Lianhan
, Zou, Jun
, Xie, Xuelei
, Wu, Xudong
, Bai, Tao
, Li, Caihong
, Wang, Shuzhen
, Zhan, Haiyan
, Song, Bin
, Wang, Yeming
, Yuan, Ye
, Wang, Ke
, Xiang, Jie
, Ge, Qin
, Fan, Guohui
, Dong, Xuan
, Liu, Ying
, Wang, Jingli
, Zhou, Xia
, Lu, Sixia
, Xia, Jiaan
, Xu, Jiuyang
, Li, Huadong
, Zhou, Fei
, Liu, Wen
, Luo, Shanshan
, Yu, Ting
, Hu, Xujuan
, Gong, Fengyun
, Zhang, Yi
, Cheng, Fang
, Huang, Chaolin
, Wei, Yuan
, Huang, Hanping
, Pan, Lihong
, Chen, Hua
, Jia, Chunmin
, Gu, Xiaoying
, Dong, Chongya
, Wei, Ming
, Zhang, Li
, Liu, Zhibo
, Li, Hui
, Ruan, Lianguo
, Wang, Juan
, Liu, Xia
, Wu, Jing
, Qiu, Fang
, Wen, Danning
, Tu, Shengjing
, Cao, Bin
, Cai, Yanping
, Horby, Peter W
, Li, Xingwang
, Wang, Chen
in
Adult
/ Aged
/ Antiretroviral drugs
/ Antiviral Agents - adverse effects
/ Antiviral Agents - therapeutic use
/ Antiviral drugs
/ Betacoronavirus - genetics
/ Betacoronavirus - isolation & purification
/ Clinical Laboratory Techniques
/ Clinical outcomes
/ Clinical trials
/ Coronavirus Infections - diagnosis
/ Coronavirus Infections - drug therapy
/ Coronavirus Infections - mortality
/ Coronavirus Infections - virology
/ Coronaviruses
/ COVID-19
/ COVID-19 Testing
/ Cytochrome P-450 CYP3A Inhibitors - adverse effects
/ Cytochrome P-450 CYP3A Inhibitors - therapeutic use
/ Drug Therapy, Combination
/ Female
/ HIV
/ Hospital Mortality
/ Human immunodeficiency virus
/ Humans
/ Influenza
/ Intention to Treat Analysis
/ Laboratories
/ Lopinavir
/ Lopinavir - adverse effects
/ Lopinavir - therapeutic use
/ Male
/ Middle Aged
/ Middle East respiratory syndrome
/ Original
/ Oxygen
/ Pandemics
/ Patient Acuity
/ Patients
/ Pneumonia
/ Pneumonia, Viral - drug therapy
/ Pneumonia, Viral - mortality
/ Pneumonia, Viral - virology
/ Proportional Hazards Models
/ Respiratory diseases
/ Reverse Transcriptase Polymerase Chain Reaction
/ Ribonucleic acid
/ Ritonavir
/ Ritonavir - adverse effects
/ Ritonavir - therapeutic use
/ RNA
/ SARS-CoV-2
/ Severe acute respiratory syndrome coronavirus 2
/ Time-to-Treatment
/ Treatment Failure
/ Viral Load
2020
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
by
Guo, Li
, Zhang, Dingyu
, Qu, Zhaohui
, Peng, Lu
, Li, Kunxia
, Jaki, Thomas
, Ruan, Shunan
, Hayden, Frederick G
, Chen, Nanshan
, He, Jing
, Shang, Lianhan
, Zou, Jun
, Xie, Xuelei
, Wu, Xudong
, Bai, Tao
, Li, Caihong
, Wang, Shuzhen
, Zhan, Haiyan
, Song, Bin
, Wang, Yeming
, Yuan, Ye
, Wang, Ke
, Xiang, Jie
, Ge, Qin
, Fan, Guohui
, Dong, Xuan
, Liu, Ying
, Wang, Jingli
, Zhou, Xia
, Lu, Sixia
, Xia, Jiaan
, Xu, Jiuyang
, Li, Huadong
, Zhou, Fei
, Liu, Wen
, Luo, Shanshan
, Yu, Ting
, Hu, Xujuan
, Gong, Fengyun
, Zhang, Yi
, Cheng, Fang
, Huang, Chaolin
, Wei, Yuan
, Huang, Hanping
, Pan, Lihong
, Chen, Hua
, Jia, Chunmin
, Gu, Xiaoying
, Dong, Chongya
, Wei, Ming
, Zhang, Li
, Liu, Zhibo
, Li, Hui
, Ruan, Lianguo
, Wang, Juan
, Liu, Xia
, Wu, Jing
, Qiu, Fang
, Wen, Danning
, Tu, Shengjing
, Cao, Bin
, Cai, Yanping
, Horby, Peter W
, Li, Xingwang
, Wang, Chen
in
Adult
/ Aged
/ Antiretroviral drugs
/ Antiviral Agents - adverse effects
/ Antiviral Agents - therapeutic use
/ Antiviral drugs
/ Betacoronavirus - genetics
/ Betacoronavirus - isolation & purification
/ Clinical Laboratory Techniques
/ Clinical outcomes
/ Clinical trials
/ Coronavirus Infections - diagnosis
/ Coronavirus Infections - drug therapy
/ Coronavirus Infections - mortality
/ Coronavirus Infections - virology
/ Coronaviruses
/ COVID-19
/ COVID-19 Testing
/ Cytochrome P-450 CYP3A Inhibitors - adverse effects
/ Cytochrome P-450 CYP3A Inhibitors - therapeutic use
/ Drug Therapy, Combination
/ Female
/ HIV
/ Hospital Mortality
/ Human immunodeficiency virus
/ Humans
/ Influenza
/ Intention to Treat Analysis
/ Laboratories
/ Lopinavir
/ Lopinavir - adverse effects
/ Lopinavir - therapeutic use
/ Male
/ Middle Aged
/ Middle East respiratory syndrome
/ Original
/ Oxygen
/ Pandemics
/ Patient Acuity
/ Patients
/ Pneumonia
/ Pneumonia, Viral - drug therapy
/ Pneumonia, Viral - mortality
/ Pneumonia, Viral - virology
/ Proportional Hazards Models
/ Respiratory diseases
/ Reverse Transcriptase Polymerase Chain Reaction
/ Ribonucleic acid
/ Ritonavir
/ Ritonavir - adverse effects
/ Ritonavir - therapeutic use
/ RNA
/ SARS-CoV-2
/ Severe acute respiratory syndrome coronavirus 2
/ Time-to-Treatment
/ Treatment Failure
/ Viral Load
2020
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
by
Guo, Li
, Zhang, Dingyu
, Qu, Zhaohui
, Peng, Lu
, Li, Kunxia
, Jaki, Thomas
, Ruan, Shunan
, Hayden, Frederick G
, Chen, Nanshan
, He, Jing
, Shang, Lianhan
, Zou, Jun
, Xie, Xuelei
, Wu, Xudong
, Bai, Tao
, Li, Caihong
, Wang, Shuzhen
, Zhan, Haiyan
, Song, Bin
, Wang, Yeming
, Yuan, Ye
, Wang, Ke
, Xiang, Jie
, Ge, Qin
, Fan, Guohui
, Dong, Xuan
, Liu, Ying
, Wang, Jingli
, Zhou, Xia
, Lu, Sixia
, Xia, Jiaan
, Xu, Jiuyang
, Li, Huadong
, Zhou, Fei
, Liu, Wen
, Luo, Shanshan
, Yu, Ting
, Hu, Xujuan
, Gong, Fengyun
, Zhang, Yi
, Cheng, Fang
, Huang, Chaolin
, Wei, Yuan
, Huang, Hanping
, Pan, Lihong
, Chen, Hua
, Jia, Chunmin
, Gu, Xiaoying
, Dong, Chongya
, Wei, Ming
, Zhang, Li
, Liu, Zhibo
, Li, Hui
, Ruan, Lianguo
, Wang, Juan
, Liu, Xia
, Wu, Jing
, Qiu, Fang
, Wen, Danning
, Tu, Shengjing
, Cao, Bin
, Cai, Yanping
, Horby, Peter W
, Li, Xingwang
, Wang, Chen
in
Adult
/ Aged
/ Antiretroviral drugs
/ Antiviral Agents - adverse effects
/ Antiviral Agents - therapeutic use
/ Antiviral drugs
/ Betacoronavirus - genetics
/ Betacoronavirus - isolation & purification
/ Clinical Laboratory Techniques
/ Clinical outcomes
/ Clinical trials
/ Coronavirus Infections - diagnosis
/ Coronavirus Infections - drug therapy
/ Coronavirus Infections - mortality
/ Coronavirus Infections - virology
/ Coronaviruses
/ COVID-19
/ COVID-19 Testing
/ Cytochrome P-450 CYP3A Inhibitors - adverse effects
/ Cytochrome P-450 CYP3A Inhibitors - therapeutic use
/ Drug Therapy, Combination
/ Female
/ HIV
/ Hospital Mortality
/ Human immunodeficiency virus
/ Humans
/ Influenza
/ Intention to Treat Analysis
/ Laboratories
/ Lopinavir
/ Lopinavir - adverse effects
/ Lopinavir - therapeutic use
/ Male
/ Middle Aged
/ Middle East respiratory syndrome
/ Original
/ Oxygen
/ Pandemics
/ Patient Acuity
/ Patients
/ Pneumonia
/ Pneumonia, Viral - drug therapy
/ Pneumonia, Viral - mortality
/ Pneumonia, Viral - virology
/ Proportional Hazards Models
/ Respiratory diseases
/ Reverse Transcriptase Polymerase Chain Reaction
/ Ribonucleic acid
/ Ritonavir
/ Ritonavir - adverse effects
/ Ritonavir - therapeutic use
/ RNA
/ SARS-CoV-2
/ Severe acute respiratory syndrome coronavirus 2
/ Time-to-Treatment
/ Treatment Failure
/ Viral Load
2020
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Journal Article
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
2020
Request Book From Autostore
and Choose the Collection Method
Overview
Investigators in China report the results of an open-label, randomized clinical trial of lopinavir–ritonavir for the treatment of Covid-19 in 199 infected adult patients. The primary end point was the time to clinical improvement.
Publisher
Massachusetts Medical Society
Subject
/ Aged
/ Antiviral Agents - adverse effects
/ Antiviral Agents - therapeutic use
/ Betacoronavirus - isolation & purification
/ Clinical Laboratory Techniques
/ Coronavirus Infections - diagnosis
/ Coronavirus Infections - drug therapy
/ Coronavirus Infections - mortality
/ Coronavirus Infections - virology
/ COVID-19
/ Cytochrome P-450 CYP3A Inhibitors - adverse effects
/ Cytochrome P-450 CYP3A Inhibitors - therapeutic use
/ Female
/ HIV
/ Human immunodeficiency virus
/ Humans
/ Male
/ Middle East respiratory syndrome
/ Original
/ Oxygen
/ Patients
/ Pneumonia, Viral - drug therapy
/ Pneumonia, Viral - mortality
/ Reverse Transcriptase Polymerase Chain Reaction
/ RNA
This website uses cookies to ensure you get the best experience on our website.